Publication Author: Patrick_Donald
-
The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice.
Patrick DL, Giuliano F, Ho KF, Gagnon DD, McNulty P, Rothman M. The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice. BJU Int. 2009 Feb;103(3):358-64. Epub 2008 Sep 12.
rakerr2
-
Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia.
Patrick DL, Burns T, Morosini P, Rothman M, Gagnon DD, Wild D, Adriaenssen I. Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia. Curr Med Res Op
rakerr2
-
Development and validation of an onset of effect questionnaire for patients with asthma.
Leidy NK, Mathias SD, Parasuraman BM, Patrick DL, Pathak D. Development and validation of an onset of effect questionnaire for patients with asthma. Allergy Asthma Proc. 2008 Nov-Dec;29(6):590-9. Epub 2008 Sep 4.
rakerr2
-
Further validation of an individualized migraine treatment satisfaction measure.
Martin ML, Patrick DL, Bushnell DM, Gandra SR, Gilchrist K. Further validation of an individualized migraine treatment satisfaction measure. Value Health. 2008 Sep-Oct;11(5):904-12. Epub 2008 May 20.
rakerr2
-
Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
Shabsigh R, Patrick DL, Rowland DL, Bull SA, Tesfaye F, Rothman M. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine. BJU Int. 2008 Sep;102(7):824-8. Epub 20
rakerr2
-
Premature ejaculation: results from a five-country European observational study.
Giuliano F, Patrick DL, Porst H, La Pera G, Kokoszka A, Merchant S, Rothman M, Gagnon DD, Polverejan E; 3004 Study Group. Premature ejaculation: results from a five-country European observational study. Eur Urol. 2008 May;53(5):1048-57. Epub 2007 Oct 16.
rakerr2
-
Validation of the Multiple Sclerosis International Quality of Life questionnaire.
Simeoni M, Auquier P, Fernandez O, Flachenecker P, Stecchi S, Constantinescu C, Idiman E, Boyko A, Beiske A, Vollmer T, Triantafyllou N, O’Connor P, Barak Y, Biermann L, Cristiano E, Atweh S, Patrick D, Robitail S, Ammoury N, Beresniak A, Pelletier J; Mus
rakerr2
-
Patient-reported outcomes to support medical product labeling claims: FDA perspective.
Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O’Neill R, Kennedy DL. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007 Nov-Dec;10 Suppl 2:S125-37. Review.
rakerr2
-
A lifestyle-based weight management program delivered to employees: examination of health and economic outcomes.
Hughes MC, Girolami TM, Cheadle AD, Harris JR, Patrick DL. A lifestyle-based weight management program delivered to employees: examination of health and economic outcomes. J Occup Environ Med. 2007 Nov;49(11):1212-7.
rakerr2
-
Methods to determine the minimum important difference for a sexual event diary used by postmenopausal women with hypoactive sexual desire disorder.
Symonds T, Spino C, Sisson M, Soni P, Martin M, Gunter L, Patrick DL. Methods to determine the minimum important difference for a sexual event diary used by postmenopausal women with hypoactive sexual desire disorder. J Sex Med. 2007 Sep;4(5):1328-35.
rakerr2